374 related articles for article (PubMed ID: 16713576)
1. Central pore residues mediate the p97/VCP activity required for ERAD.
DeLaBarre B; Christianson JC; Kopito RR; Brunger AT
Mol Cell; 2006 May; 22(4):451-62. PubMed ID: 16713576
[TBL] [Abstract][Full Text] [Related]
2. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation.
Weihl CC; Dalal S; Pestronk A; Hanson PI
Hum Mol Genet; 2006 Jan; 15(2):189-99. PubMed ID: 16321991
[TBL] [Abstract][Full Text] [Related]
3. Regulation of ER-associated degradation via p97/VCP-interacting motif.
Ballar P; Fang S
Biochem Soc Trans; 2008 Oct; 36(Pt 5):818-22. PubMed ID: 18793143
[TBL] [Abstract][Full Text] [Related]
4. Mutations in p97/VCP induce unfolding activity.
Rothballer A; Tzvetkov N; Zwickl P
FEBS Lett; 2007 Mar; 581(6):1197-201. PubMed ID: 17346713
[TBL] [Abstract][Full Text] [Related]
5. Complete structure of p97/valosin-containing protein reveals communication between nucleotide domains.
DeLaBarre B; Brunger AT
Nat Struct Biol; 2003 Oct; 10(10):856-63. PubMed ID: 12949490
[TBL] [Abstract][Full Text] [Related]
6. BRSK2 is a valosin-containing protein (VCP)-interacting protein that affects VCP functioning in endoplasmic reticulum-associated degradation.
Wang Y; Wan B; Zhou J; Li R; Yu L
Biotechnol Lett; 2013 Dec; 35(12):1983-9. PubMed ID: 23907667
[TBL] [Abstract][Full Text] [Related]
7. Ubxd1 is a novel co-factor of the human p97 ATPase.
Madsen L; Andersen KM; Prag S; Moos T; Semple CA; Seeger M; Hartmann-Petersen R
Int J Biochem Cell Biol; 2008; 40(12):2927-42. PubMed ID: 18656546
[TBL] [Abstract][Full Text] [Related]
8. p97/valosin-containing protein (VCP) is highly modulated by phosphorylation and acetylation.
Mori-Konya C; Kato N; Maeda R; Yasuda K; Higashimae N; Noguchi M; Koike M; Kimura Y; Ohizumi H; Hori S; Kakizuka A
Genes Cells; 2009 Apr; 14(4):483-97. PubMed ID: 19335618
[TBL] [Abstract][Full Text] [Related]
9. A conserved unfoldase activity for the p97 AAA-ATPase in proteasomal degradation.
Beskow A; Grimberg KB; Bott LC; Salomons FA; Dantuma NP; Young P
J Mol Biol; 2009 Dec; 394(4):732-46. PubMed ID: 19782090
[TBL] [Abstract][Full Text] [Related]
10. Going through the motions: the ATPase cycle of p97.
Pye VE; Dreveny I; Briggs LC; Sands C; Beuron F; Zhang X; Freemont PS
J Struct Biol; 2006 Oct; 156(1):12-28. PubMed ID: 16621604
[TBL] [Abstract][Full Text] [Related]
11. UBXD1 is a VCP-interacting protein that is involved in ER-associated degradation.
Nagahama M; Ohnishi M; Kawate Y; Matsui T; Miyake H; Yuasa K; Tani K; Tagaya M; Tsuji A
Biochem Biophys Res Commun; 2009 May; 382(2):303-8. PubMed ID: 19275885
[TBL] [Abstract][Full Text] [Related]
12. A unique IBMPFD-related P97/VCP mutation with differential binding pattern and subcellular localization.
Erzurumlu Y; Kose FA; Gozen O; Gozuacik D; Toth EA; Ballar P
Int J Biochem Cell Biol; 2013 Apr; 45(4):773-82. PubMed ID: 23333620
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the aggregation-prevention activity of p97/valosin-containing protein.
Song C; Wang Q; Li CC
Biochemistry; 2007 Dec; 46(51):14889-98. PubMed ID: 18044963
[TBL] [Abstract][Full Text] [Related]
14. Derlin-1 and p97/valosin-containing protein mediate the endoplasmic reticulum-associated degradation of human V2 vasopressin receptors.
Schwieger I; Lautz K; Krause E; Rosenthal W; Wiesner B; Hermosilla R
Mol Pharmacol; 2008 Mar; 73(3):697-708. PubMed ID: 18048502
[TBL] [Abstract][Full Text] [Related]
15. Structural and mechanistic insights into the arginine/lysine-rich peptide motifs that interact with P97/VCP.
Liu S; Fu QS; Zhao J; Hu HY
Biochim Biophys Acta; 2013 Dec; 1834(12):2672-8. PubMed ID: 24100225
[TBL] [Abstract][Full Text] [Related]
16. Novel p97/VCP inhibitor induces endoplasmic reticulum stress and apoptosis in both bortezomib-sensitive and -resistant multiple myeloma cells.
Nishimura N; Radwan MO; Amano M; Endo S; Fujii E; Hayashi H; Ueno S; Ueno N; Tatetsu H; Hata H; Okamoto Y; Otsuka M; Mitsuya H; Matsuoka M; Okuno Y
Cancer Sci; 2019 Oct; 110(10):3275-3287. PubMed ID: 31368616
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional implications of phosphorylation and acetylation in the regulation of the AAA+ protein p97.
Ewens CA; Kloppsteck P; Förster A; Zhang X; Freemont PS
Biochem Cell Biol; 2010 Feb; 88(1):41-8. PubMed ID: 20130678
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of transient binding and release of substrate protein during the allosteric cycle of the p97 nanomachine.
Tonddast-Navaei S; Stan G
J Am Chem Soc; 2013 Oct; 135(39):14627-36. PubMed ID: 24007343
[TBL] [Abstract][Full Text] [Related]
19. Nucleotide dependent motion and mechanism of action of p97/VCP.
DeLaBarre B; Brunger AT
J Mol Biol; 2005 Mar; 347(2):437-52. PubMed ID: 15740751
[TBL] [Abstract][Full Text] [Related]
20. AAA ATPase p97/VCP: cellular functions, disease and therapeutic potential.
Vij N
J Cell Mol Med; 2008 Dec; 12(6A):2511-8. PubMed ID: 18798739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]